Brishna Kamal, President and Co-Founder
Brishna grew up in northern Afghanistan, hailing from the same mountainous region that much of the world’s C. indica medical cannabis originated. Brishna received a M.Sc. in Neuroscience from McGill University (2014), studying age-related cortical plasticity. After graduate studies, she became interested in cannabinoid pharmacology, and served as the Chief Research Officer at Whistler Medical Marijuana Corp. Recently, Brishna has co-founded Whistler Therapeutics and hopes to contribute to the body of research legitimizing cannabis based therapeutics.
Daniel Lantela, Co-Founder and Director of Drug Development
Daniel received a Bachelors and Master of Science in Biochemistry. He developed an interest in the anti-cancer properties of cannabis, spending extensive time studying the published literature. At Whistler Medical Marijuana Corporation (WMMC), he has developed the cannabis oil program from scratch using a new process to create a higher quality and organic cannabis oil. Daniel is the Co-Founder and Director of Drug Development here at Whistler Therapeutics.